← Back to search results

plannedFind a Tender · planning

NHS Community Anticoagulation Services

Buyer: NHS North East London Integrated Care Board →

BuyerNHS North East London Integrated Care Board
Statusplanned
DeadlineNot published
ValueValue not published
Published10 Apr 2025

What is being bought

NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process. We are not required to actively invite anyone to express interest but rather seek to notify the market of the intention. The PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available. Further details, including procurement timelines and engagement opportunities, will be communicated in due course. Interested providers are encouraged to express their interest and stay informed about the process. For enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ-2149

Delivery location

UKI

Categories

Miscellaneous health services 85140000

Lot details

Lot 1

NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process. We are not required to actively invite anyone to express interest but rather seek to notify the market of the intention. The PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available. Further details, including procurement timelines and engagement opportunities, will be communicated in due course. Interested providers are encouraged to express their interest and stay informed about the process. For enquiries or to register interest, please contact hub.queries@nhs.net Patients will be referred to the service from; • General Practice • Secondary Care- including patients whose anticoagulation therapy has been previously initiated and managed by acute services. The specification requires the provider to deliver : 1. Warfarin initiation and stablisation for Non-Valvular Atrial Fibrillation (NVAF). 2. Warfarin monitoring and maintenance dose adjustments for patients established on warfarin. 3. Direct Oral Anticoagulant (DOAC) initiation for NVAF, followed by transfer of care to patient's registered GP. 4. Switching from warfarin to DOAC for NVAF, followed by transfer to patient's GP 5. The management of excursions from target INR. This is to be in consultation with secondary care specialists when the initiation of treatments to mitigate the impact of under or over anticoagulation with warfarin is necessary. 6. Switching suitable patients from warfarin to DOAC for NVAF, followed by transfer to patient's registered GP. 7. Where necessary, escalation of complex patients to secondary care specialists, with referral back to secondary care for ongoing monitoring, to be decided on a case-by-case basis. 8. Domiciliary visits where patient fits the criteria. Additional information: The anticoagulation service provider will be responsible for ensuring that the service is provided according to the service specification. The key aspects of the service specification providers must meet are; • Provision of a community-based anticoagulant management and monitoring service that is clinically appropriate, cost effective and in line with guidance from NICE, the British Committee for Standards in Haematology and recommendations from the 2007 National Patient Safety Agency Alert: Safer use of anticoagulants. • To have a designated named clinical lead responsible for the safe and effective delivery of the commissioned service. • To ensure all staff working in the service have the necessary knowledge, skills, competencies and access to ongoing training, as set out by the service specification, in order to meet the requirements of their role. • To have a range of standard operating procedures in place to cover the key tasks and patient interventions underpinning the service. • To ensure the service is accessible in terms of location and opening hours. • To offer the service in a one-stop clinic offering patient education, anticoagulant treatment discussions INR testing, and drug/dose changes in the same consultation. • To ensure each interaction, whether a routine visit or a warfarin annual review , is recorded in a standardised template which will be made accessible in the patient's registered GP record. • To have a clear escalation process for clinical queries depending on the nature and urgency of the query, including establishing working relationships with secondary care. • To report all Serious Incidents and Never Events in accordance with the requirements of relevant Frameworks. • To run the service with all appropriate Quality Control processes for point of care testing equipment and materials. • To safely manage, document and communicate the cessation of anticoagulation as advised by the specialist. • To report in a timely manner all relevant KPIs and financial data as indicated in the specification. • To ensure appropriate communication of patient care with the patient's GP (if the service provider is different), community pharmacy, care home (if relevant) and the appropriate secondary care anticoagulation service, if needed.

Statusplanned

What is included

ItemCategoryQuantity
1Not publishedNot published

Comparable-procurement analytics

Benchmarked against retained Find a Tender procedures with CPV division 85. The category anchor is Miscellaneous health services (85140000); this is a deliberately broad market comparator. The comparison is shown at several levels rather than pretending one company or region is always the best benchmark.

Comparison setProceduresReported bids per procedureNamed award suppliersPrice evidence
Market: CPV division 8538,3731 median · 19.7 average (22,930 of 38,373 with a bid count)1.8 average (24,592 of 38,373 with named award suppliers)10 comparable price pairs
Same buyer611 median · 2.4 average (21 of 61 with a bid count)1 average (26 of 61 with named award suppliers)Not published
Delivery region: UKI1,1221 median · 9.5 average (463 of 1,122 with a bid count)1.7 average (528 of 1,122 with named award suppliers)Not published

“Reported bids” is an official aggregate, sometimes reported per lot; it is the closest available competition measure. “Named award suppliers” are winners, not all applicants.

Price-outcome signal

Not enough comparable procedures currently publish both a GBP tender value and a usable lowest-valid-bid value to calculate a responsible price-reduction benchmark. Tenderline deliberately does not infer a saving from named award suppliers or from missing award values.

Procurement strategy & market signals

Framework agreementNot published
Dynamic purchasing systemNot published
Competitive procurementNot published
Recurring requirementNot published
Procurement method rationaleNot published
Rationale classificationsNot published
Special regimeNot published
Covered byGPA
Submission policyNot published
Selection criteriaNot published
Risk detailsNot published

Planning & early market engagement

BudgetNot published
No-engagement rationaleNot published
Planning documents0
Planning milestones0

No planning milestones published.

Related procurements

No linked framework, prior procurement or reprocurement published.

Documents & submission route

No documents are published in the current source record.

Source data inventory

Diagnostic view. “Not published” means this current release does not provide a value.

OCIDocds-h6vhtk-0500cd
Latest release ID014374-2025
Latest release timestampThu Apr 10 2025 15:10:55 GMT+0000 (Coordinated Universal Time)
Sourcefind-a-tender
Official notice URLNot published
Tender statusplanned
Procurement methodNot published
Procurement method detailsNot published
Main procurement categoryservices
Above thresholdNot published
Legal basis32014L0024
Tender period: startNot published
Tender period: endNot published
Expression of interest deadlineNot published
Enquiry deadlineNot published
Award period: startNot published
Award period: endNot published
Submission method detailsNot published
Submission languagesNot published
Electronic catalogue policyNot published
Total tender valueNot published
Tender lots in source1
Tender items in source1
Tender documents in source0
Awards in latest release0
Contracts in latest release0
Parties in latest release1

Notice history

DateEventReference
10 Apr 2025planning014374-2025

All source data

Unmodified official OCDS data retained by Tenderline for this procurement process.

Complete current OCDS release JSON
{
  "id": "014374-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-04-10T16:10:55+01:00",
  "ocid": "ocds-h6vhtk-0500cd",
  "buyer": {
    "id": "GB-NHS-QMF",
    "name": "NHS North East London Integrated Care Board"
  },
  "tender": {
    "id": "PRJ-2149",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. \nThis Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net\nPatients will be referred to the service from;\n•\tGeneral Practice \n•\tSecondary Care- including patients whose anticoagulation therapy has been previously initiated and managed by acute services.\nThe specification requires the provider to deliver : \n1.\tWarfarin initiation and stablisation for Non-Valvular Atrial Fibrillation (NVAF).\n2.\tWarfarin monitoring and maintenance dose adjustments for patients established on warfarin.\n3.\tDirect Oral Anticoagulant (DOAC) initiation for NVAF, followed by transfer of care to patient's registered GP. \n4.\tSwitching from warfarin to DOAC for NVAF, followed by transfer to patient's GP\n5.\tThe management of excursions from target INR. This is to be in consultation with secondary care specialists when the initiation of treatments to mitigate the impact of under or over anticoagulation with warfarin is necessary.  \n6.\tSwitching suitable patients from warfarin to DOAC for NVAF, followed by transfer to patient's registered GP.\n7.\tWhere necessary, escalation of complex patients to secondary care specialists, with referral back to secondary care for ongoing monitoring, to be decided on a case-by-case basis. \n8.\tDomiciliary visits where patient fits the criteria. Additional information: The anticoagulation service provider will be responsible for ensuring that the service is provided according to the service specification. The key aspects of the service specification providers must meet are;\n•\tProvision of a community-based anticoagulant management and monitoring service that is clinically appropriate, cost effective and in line with guidance from NICE, the British Committee for Standards in Haematology and recommendations from the 2007 National Patient Safety Agency Alert: Safer use of anticoagulants. \n•\tTo have a designated named clinical lead responsible for the safe and effective delivery of the commissioned service.\n•\tTo ensure all staff working in the service have the necessary knowledge, skills, competencies and access to ongoing training, as set out by the service specification, in order to meet the requirements of their role.  \n•\tTo have a range of standard operating procedures in place to cover the key tasks and patient interventions underpinning the service. \n•\tTo ensure the service is accessible in terms of location and opening hours.\n•\tTo offer the service in a one-stop clinic offering patient education, anticoagulant treatment discussions INR testing, and drug/dose changes in the same consultation. \n•\tTo ensure each interaction, whether a routine visit or a warfarin annual review , is recorded in a standardised template which will be made accessible in the patient's registered GP record. \n•\tTo have a clear escalation process for clinical queries depending on the nature and urgency of the query, including establishing working relationships with secondary care.\n•\tTo report all Serious Incidents and Never Events in accordance with the requirements of relevant Frameworks. \n•\tTo run the service with all appropriate Quality Control processes for point of care testing equipment and materials.\n•\tTo safely manage, document and communicate the cessation of anticoagulation as advised by the specialist.\n•\tTo report in a timely manner all relevant KPIs and financial data as indicated in the specification.\n•\tTo ensure appropriate communication of patient care with the patient's GP (if the service provider is different), community pharmacy, care home (if relevant) and the appropriate secondary care anticoagulation service, if needed."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "North East London"
        },
        "deliveryAddresses": [
          {
            "region": "UKI"
          }
        ]
      }
    ],
    "title": "NHS Community Anticoagulation Services",
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ-2149",
    "communication": {
      "futureNoticeDate": "2025-05-30T00:00:00+01:00"
    },
    "classification": {
      "id": "85140000",
      "scheme": "CPV",
      "description": "Miscellaneous health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-NHS-QMF",
      "name": "NHS North East London Integrated Care Board",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI41",
        "locality": "London",
        "postalCode": "E151DA",
        "countryName": "United Kingdom",
        "streetAddress": "4th Floor - Unex Tower, 5 Station Street"
      },
      "details": {
        "url": "https://northeastlondon.icb.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "QMF",
        "scheme": "GB-NHS",
        "legalName": "NHS North East London Integrated Care Board"
      },
      "contactPoint": {
        "email": "hub.queries@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}
Complete JSON history (1 releases)
10 Apr 2025 · 014374-2025 · planning
{
  "id": "014374-2025",
  "tag": [
    "planning"
  ],
  "date": "2025-04-10T16:10:55+01:00",
  "ocid": "ocds-h6vhtk-0500cd",
  "buyer": {
    "id": "GB-NHS-QMF",
    "name": "NHS North East London Integrated Care Board"
  },
  "tender": {
    "id": "PRJ-2149",
    "lots": [
      {
        "id": "1",
        "status": "planned",
        "description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. \nThis Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net\nPatients will be referred to the service from;\n•\tGeneral Practice \n•\tSecondary Care- including patients whose anticoagulation therapy has been previously initiated and managed by acute services.\nThe specification requires the provider to deliver : \n1.\tWarfarin initiation and stablisation for Non-Valvular Atrial Fibrillation (NVAF).\n2.\tWarfarin monitoring and maintenance dose adjustments for patients established on warfarin.\n3.\tDirect Oral Anticoagulant (DOAC) initiation for NVAF, followed by transfer of care to patient's registered GP. \n4.\tSwitching from warfarin to DOAC for NVAF, followed by transfer to patient's GP\n5.\tThe management of excursions from target INR. This is to be in consultation with secondary care specialists when the initiation of treatments to mitigate the impact of under or over anticoagulation with warfarin is necessary.  \n6.\tSwitching suitable patients from warfarin to DOAC for NVAF, followed by transfer to patient's registered GP.\n7.\tWhere necessary, escalation of complex patients to secondary care specialists, with referral back to secondary care for ongoing monitoring, to be decided on a case-by-case basis. \n8.\tDomiciliary visits where patient fits the criteria. Additional information: The anticoagulation service provider will be responsible for ensuring that the service is provided according to the service specification. The key aspects of the service specification providers must meet are;\n•\tProvision of a community-based anticoagulant management and monitoring service that is clinically appropriate, cost effective and in line with guidance from NICE, the British Committee for Standards in Haematology and recommendations from the 2007 National Patient Safety Agency Alert: Safer use of anticoagulants. \n•\tTo have a designated named clinical lead responsible for the safe and effective delivery of the commissioned service.\n•\tTo ensure all staff working in the service have the necessary knowledge, skills, competencies and access to ongoing training, as set out by the service specification, in order to meet the requirements of their role.  \n•\tTo have a range of standard operating procedures in place to cover the key tasks and patient interventions underpinning the service. \n•\tTo ensure the service is accessible in terms of location and opening hours.\n•\tTo offer the service in a one-stop clinic offering patient education, anticoagulant treatment discussions INR testing, and drug/dose changes in the same consultation. \n•\tTo ensure each interaction, whether a routine visit or a warfarin annual review , is recorded in a standardised template which will be made accessible in the patient's registered GP record. \n•\tTo have a clear escalation process for clinical queries depending on the nature and urgency of the query, including establishing working relationships with secondary care.\n•\tTo report all Serious Incidents and Never Events in accordance with the requirements of relevant Frameworks. \n•\tTo run the service with all appropriate Quality Control processes for point of care testing equipment and materials.\n•\tTo safely manage, document and communicate the cessation of anticoagulation as advised by the specialist.\n•\tTo report in a timely manner all relevant KPIs and financial data as indicated in the specification.\n•\tTo ensure appropriate communication of patient care with the patient's GP (if the service provider is different), community pharmacy, care home (if relevant) and the appropriate secondary care anticoagulation service, if needed."
      }
    ],
    "items": [
      {
        "id": "1",
        "relatedLot": "1",
        "deliveryLocation": {
          "description": "North East London"
        },
        "deliveryAddresses": [
          {
            "region": "UKI"
          }
        ]
      }
    ],
    "title": "NHS Community Anticoagulation Services",
    "status": "planned",
    "coveredBy": [
      "GPA"
    ],
    "legalBasis": {
      "id": "32014L0024",
      "scheme": "CELEX"
    },
    "description": "NHS NEL ICB is in the process of re-commissioning a new Community Anticoagulation Services. This Prior Information Notice (PIN) serves as the intention to follow the Most Suitable Provider (MSP) process.\nWe are not required to actively invite anyone to express interest but rather seek to notify the market of the intention.\nThe PIN outlines the scope, key service features, criteria, and expectations for providers interested in bidding when the opportunity becomes available.\nFurther details, including procurement timelines and engagement opportunities, will be communicated in due course. \nInterested providers are encouraged to express their interest and stay informed about the process.\nFor enquiries or to register interest, please contact hub.queries@nhs.net using reference number PRJ-2149",
    "communication": {
      "futureNoticeDate": "2025-05-30T00:00:00+01:00"
    },
    "classification": {
      "id": "85140000",
      "scheme": "CPV",
      "description": "Miscellaneous health services"
    },
    "mainProcurementCategory": "services"
  },
  "parties": [
    {
      "id": "GB-NHS-QMF",
      "name": "NHS North East London Integrated Care Board",
      "roles": [
        "buyer"
      ],
      "address": {
        "region": "UKI41",
        "locality": "London",
        "postalCode": "E151DA",
        "countryName": "United Kingdom",
        "streetAddress": "4th Floor - Unex Tower, 5 Station Street"
      },
      "details": {
        "url": "https://northeastlondon.icb.nhs.uk/",
        "classifications": [
          {
            "id": "BODY_PUBLIC",
            "scheme": "TED_CA_TYPE",
            "description": "Body governed by public law"
          },
          {
            "id": "07",
            "scheme": "COFOG",
            "description": "Health"
          }
        ]
      },
      "identifier": {
        "id": "QMF",
        "scheme": "GB-NHS",
        "legalName": "NHS North East London Integrated Care Board"
      },
      "contactPoint": {
        "email": "hub.queries@nhs.net"
      }
    }
  ],
  "language": "en",
  "initiationType": "tender"
}